Found: 23
Select item for more details and to access through your institution.
Invasive Group A Streptococcus Hypervirulent M1<sub>UK</sub> Clone, Canada, 2018-2023.
- Published in:
- Emerging Infectious Diseases, 2024, v. 30, n. 11, p. 2409, doi. 10.3201/eid3011.241068
- By:
- Publication type:
- Article
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 533, doi. 10.1007/s40265-022-01688-1
- By:
- Publication type:
- Article
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
- Published in:
- Drugs, 2019, v. 79, n. 3, p. 271, doi. 10.1007/s40265-019-1055-2
- By:
- Publication type:
- Article
Invasive group A streptococcal disease surveillance in Canada, 2021–2022.
- Published in:
- Canada Communicable Disease Report, 2024, v. 50, n. 5, p. 135, doi. 10.14745/ccdr.v50i05a03
- By:
- Publication type:
- Article
Invasive pneumococcal disease surveillance in Canada, 2021–2022.
- Published in:
- Canada Communicable Disease Report, 2024, v. 50, n. 5, p. 121, doi. 10.14745/ccdr.v50i05a02
- By:
- Publication type:
- Article
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19.
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 1, p. 1, doi. 10.1093/jacamr/dlab197
- By:
- Publication type:
- Article
Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007–21.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 10, p. 2653, doi. 10.1093/jac/dkae272
- By:
- Publication type:
- Article
Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i26, doi. 10.1093/jac/dkad067
- By:
- Publication type:
- Article
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i8, doi. 10.1093/jac/dkad065
- By:
- Publication type:
- Article
Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011–20.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i37, doi. 10.1093/jac/dkad068
- By:
- Publication type:
- Article
Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i17, doi. 10.1093/jac/dkad066
- By:
- Publication type:
- Article
PCV-15 and PPSV-23 coverage of invasive and respiratory tract Streptococcus pneumoniae, including MDR and XDR isolates: CANWARD 2007-20.
- Published in:
- 2022
- By:
- Publication type:
- journal article
ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007–16.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv39, doi. 10.1093/jac/dkz286
- By:
- Publication type:
- Article
Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007–16.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv22, doi. 10.1093/jac/dkz284
- By:
- Publication type:
- Article
42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv5, doi. 10.1093/jac/dkz283
- By:
- Publication type:
- Article
Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 8, p. 2199, doi. 10.1093/jac/dkv107
- By:
- Publication type:
- Article
Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 7, p. 1960, doi. 10.1093/jac/dkv061
- By:
- Publication type:
- Article